Drug General Information
Drug ID
D07NYF
Former ID
DIB005893
Drug Name
MLN-2201
Synonyms
LDP-01; MLN-01; Anti-beta2-integrin MAb, LeukoSite
Drug Type
Antibody
Indication Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] Discontinued in Phase 1 [546763]
Company
LeukoSite Inc
CAS Number
CAS 339164-13-5
Target and Pathway
Target(s) Integrin beta-2 Target Info [546764]
KEGG Pathway Rap1 signaling pathway
Phagosome
Hippo signaling pathway
Cell adhesion molecules (CAMs)
Natural killer cell mediated cytotoxicity
Leukocyte transendothelial migration
Regulation of actin cytoskeleton
Pertussis
Legionellosis
Leishmaniasis
Malaria
Amoebiasis
Staphylococcus aureus infection
Tuberculosis
HTLV-I infection
Rheumatoid arthritis
Viral myocarditis
NetPath Pathway IL5 Signaling Pathway
TCR Signaling Pathway
IL2 Signaling Pathway
PANTHER Pathway Integrin signalling pathway
Pathway Interaction Database Integrin family cell surface interactions
amb2 Integrin signaling
Beta2 integrin cell surface interactions
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
CXCR3-mediated signaling events
HIF-1-alpha transcription factor network
Reactome Toll Like Receptor 4 (TLR4) Cascade
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Cell surface interactions at the vascular wall
Integrin cell surface interactions
WikiPathways Focal Adhesion
Human Complement System
Toll-Like Receptors Cascades
Integrin-mediated Cell Adhesion
Integrin cell surface interactions
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Cell surface interactions at the vascular wall
References
Ref 546763Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010178)
Ref 546764Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010178)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.